A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome
Clinical trial NCT03651726 · UNKNOWN
Trial details
- NCT number
- NCT03651726
- Sponsor
- Neurothera Labs Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2019-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.